FilingReader Intelligence

Humanwell Healthcare gets clinical trial approval for lung drug

August 5, 2025 at 05:09 PM UTCBy FilingReader AI

Humanwell Healthcare Group has received approval for clinical trials of HW241045 tablets, a treatment for idiopathic pulmonary fibrosis.

The company has invested approximately 2.3bn yuan in the project. The drug will now proceed to clinical studies before seeking production approval.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Humanwell Healthcare Group publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →